Aj. Ramsay et M. Kohonencorish, INTERLEUKIN-5 EXPRESSED BY A RECOMBINANT VIRUS VECTOR ENHANCES SPECIFIC MUCOSAL IGA RESPONSES IN-VIVO, European Journal of Immunology, 23(12), 1993, pp. 3141-3145
Several in vitro studies have shown that murine interleukin-5 (mIL-5)
enhances IgA production by activated mucosal B cells. To date, however
, there is no evidence that this factor significantly up-regulates muc
osal IgA responses in vivo. Here, we show that expression of the gene
for mIL-5 in a recombinant vaccinia virus vector markedly increases Ig
A responses to co-expressed heterologous antigen in the lungs of mice
given intranasal inocula of the virus. The elevated local IgA response
s to vectors expressing mIL-5 peaked at a fourfold higher level than t
hose elicited by control virus at 14 days after infection and were sus
tained for at least 4 weeks. Increased IgA responses were abrogated in
mice treated with monoclonal antibody against mIL-5 and were not dete
cted in systemic lymphoid tissue. No enhancement of specific IgG level
s was found either locally or systemically. Our results indicate that
mIL-5 selectively enhances the development of mucosal IgA responses in
vivo and suggest that expression of this factor in mucosal vaccine ve
ctors may stimulate local immune reactivity.